Our findings are consistent with two previous studies that comprehensively examined the role of IGF1, IGFBP1, and IGFBP3 genetic variation in relation to circulating IGF-I and IGFBP-3 levels and breast cancer risk [8], [9], [11]. Here, IGFBP3 is linked to breast carcinoma.